These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2004-002181-38 WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) 2011-07-19 bad-data
Not reported 2005-004080-28 Efficacy and Safety of Niaspan in South Asian Stroke Survivors: NIASTAR TRIAL (Niaspan: Indo-Asian Stroke patienT Atherosclerotic Regression trial) 2006-02-08 due-trials
Ongoing 2009-017176-25 Aspirin resistance and heart disease not-yet-due
Reported results 2010-021257-39 Is it clinically effective to treat arm flexor spasticity, with Botulinum toxin – type A (BoNTA) and physiotherapy, as soon as signs of abnormal muscle activity are observed? (A phase II study) 2014-05-28 due-trials
Ongoing 2012-004988-42 REVISE-Diabesity: Randomisation to Endoluminal intestinal liner alone Versus with Incretin analogue in SustainEd Diabesity not-yet-due
Reported results 2013-003107-19 Phase II clinical trial investigating the use of epigallocatechin-3-gallate (Veregen) in the treatment of vulval intraepithelial neoplasia 2019-01-07 due-trials
Completed, report not yet due 2013-004246-41 A phase III randomised study of folic acid supplementation in the management of menopausal symptoms in cancer survivors and healthy postmenopausal women 2020-03-19 not-yet-due